‹ ›
MYP_171187
← PREVIOUS NEXT → BACK
Basic Information
BF-30
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza A ▸ Anti-Influenza A virus
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
10 amino acids
C62H106N18O12
Standard
Sequence
KFFRKKSVKK
Physicochemical Analysis
1295.62 Da
11.39
5.76
5.54
0.5755
-1.50
0.19
-0.68
6.12
29.00
0.2000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
537.45
-3.20
20.0
18.0
49.0
92.0
2.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0291552 VERIFIED: YES
Provenance & Taxonomy
Bungarus fasciatus [Animal]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
influenza A virus(oseltamivir-resistant strain): inhibition of viral replication in MDCK cells
18.91±7 μM
EC50
PaperPubMed PMID: 30447229 PMID30447229 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30447229/
RECORD: Rec_0336023 VERIFIED: YES
Provenance & Taxonomy
Bungarus fasciatus [Animal]
8613
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-Influenza A virus Replication inhibition
Influenza A virus H3N2 | MDCK cells
7.36±1.2 μM
EC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperInhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion. | Xu J, Chen S, Jin J, Ma L, Guo M, Zhou C, Dou J. | Peptides. 2019 Feb;112:14-22. | DOI:10.1016/j.peptides.2018.10.004 | PMID:30447229 PMID30447229 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30447229/
RECORD: Rec_0349501 VERIFIED: YES
Provenance & Taxonomy
Bungarus fasciatus [Animal]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Influenza A virus H1N1:inhibition of viral replication in MDCK cells
5.2±0.9 μM
EC50
PaperPubMed PMID: 30447229 PMID30447229 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30447229/
RECORD: Rec_0383378 VERIFIED: YES
Provenance & Taxonomy
Bungarus fasciatus [Animal]
8613
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-Influenza A virus Replication inhibition
Influenza A virus(oseltamivir-resistant strain) | MDCK cells
18.91±7 μM
EC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperInhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion. | Xu J, Chen S, Jin J, Ma L, Guo M, Zhou C, Dou J. | Peptides. 2019 Feb;112:14-22. | DOI:10.1016/j.peptides.2018.10.004 | PMID:30447229 PMID30447229 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30447229/
FIRST PREV 1 2
Showing 4 records on this page · Page 2 of 2